Inspira Technologies has been granted a patent in Japan for their Convertible Dual Lumen Cannula device, securing exclusive rights in the medical device market until 2041. This innovative technology allows a single-lumen cannula to convert into a dual-lumen cannula intravascularly, potentially reducing infection risks and hospital costs. The company’s CEO, Dagi Ben-Noon, believes this patented device offers a more affordable solution for the market and solidifies their foundation for future revenue streams. Inspira Technologies specializes in advanced respiratory support and blood monitoring solutions, positioning themselves as a key player in the MedTech landscape.

Read more at GlobeNewswire: Inspira Technologies Granted Patent in Japan for the